BIOCOM for BIOCOM
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Advocated for legislation to permanently repeal the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Opposed legislation and policies that would undermine the US patent system, including "compulsory licenses"
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Held a reception honoring Members of Congress and congressional staff. Co-hosted a congressional briefing "Life Sciences Innovation: From Research to Cures" Co-hosted a congressional briefing "Safe Opioid Management in the Acute Care Setting: Integrated Technology Solutions to Promote Healthcare Worker and Patient Safety" Discussed drug pricing policies and their impact on innovation, including reference pricing, price transparency, Medicare negotiation, PBM rebates, protected classes, Medicare Part B and D reimbursement, and drug imporation. Advocated for PAHPA reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Budget/Appropriations BUD
Advocated for additional funding for NIH and FDA in FY2020 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.